Congress Trades

Coverage gap. Senate eFD: the last 13 checks failed; last successful check Oct 23. New filings from this source are not coming in. Newest Senate eFD filing on this site: 2026-10-21.

Source status

INCYIncyte Corporation

Healthcare · BiotechnologyNasdaqStockMkt cap $25.5B
Disclosed trades
26
0 in 30d · 1 in 90d
Politicians
4
Last trade Sep 4, 2026
Buys
15
$120K at range midpoints
Sells
9
$72K at range midpoints

Closing price · 365 days

Nov 6, 2025 – Nov 5, 2026

Monthly buys vs sells · 24 months

Counts of disclosed transactions
  • Buys
  • Sells (incl. partial)

Politicians who traded it

1 hold it now Estimated
Politicians who traded INCY
PoliticianSeatTradesBuysSellsBought (mid)Sold (mid)Last tradeEst. position Estimated
DRo KhannaHouse · CA-1722146$112K$48KSep 4, 2026$102.5K
DGilbert Ray Cisneros, Jr.House · CA-31211$8K$8KDec 22, 2020—
DDaniel S. GoldmanHouse · NY-10101$0$8KMar 6, 2023—
RRobert P. Bresnahan, Jr.House · PA-08101$0$8KMay 15, 2025—

Recent trades

Disclosed trades
PoliticianTickerAssetTypeOwnerAmountvs S&P EstimatedTradedFiledSource
DRo KhannaINCYINCYTECORPORATION CMNBuySpouse$1,001 - $15,000+9.7%Sep 4, 2026Oct 7, 202633dFilingOCR
DRo KhannaINCYINCYTECORPORATIONCMNBuySpouse$1,001 - $15,000+14.9%May 15, 2026Jun 9, 202625dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNUnknownReviewDependent$1,001 - $15,000—Mar 30, 2026Apr 7, 20268dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuySpouse$1,001 - $15,000+2.7%Jan 29, 2026Feb 6, 20268dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuyDependent$1,001 - $15,000+46.9%May 19, 2025Jun 10, 202522dFilingOCR
RRobert P. Bresnahan, Jr.INCYIncyte Corporation - Common Stock (INCY)SellSelf$1,001 - $15,000-57.0%May 15, 2025May 31, 202516dFiling
DRo KhannaINCYINCYTE CORPORATION CMNSellSpouse$1,001 - $15,000-40.4%Feb 19, 2025Mar 6, 202515dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuySpouse$1,001 - $15,000+36.6%Jan 17, 2025Feb 6, 202520dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNSellDependent$1,001 - $15,000-37.0%Dec 18, 2024Jan 8, 202521dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuyDependent$1,001 - $15,000+36.7%Nov 15, 2024Dec 5, 202420dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuySpouse$1,001 - $15,000+57.0%Aug 2, 2024Sep 6, 202435dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuySpouse$1,001 - $15,000+57.0%Aug 2, 2024Sep 6, 202435dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuyDependent$1,001 - $15,000+72.2%Mar 25, 2024Apr 5, 202411dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuySpouse$1,001 - $15,000+20.4%Dec 4, 2023Jan 4, 202431dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNSellSpouse$1,001 - $15,000-50.7%Oct 10, 2023Nov 8, 202329dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNSellDependent$1,001 - $15,000-50.7%Oct 2, 2023Nov 8, 202337dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNPartialSpouse$1,001 - $15,000-35.2%Sep 6, 2023Oct 6, 202330dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuyDependent$1,001 - $15,000+22.1%Jun 26, 2023Jul 11, 202315dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNBuySpouse$1,001 - $15,000+21.1%May 19, 2023Jun 12, 202324dFilingOCR
DDaniel S. GoldmanINCYIncyte Corporation (INCY)SellSelf$1,001 - $15,000+19.7%Mar 6, 2023Apr 17, 202342dFiling
DRo KhannaINCYINCYTECORPORATIONCMNBuySpouse$1,001 - $15,000-30.8%Jan 9, 2023Feb 7, 202329dFilingOCR
DRo KhannaINCYINCYTECORPORATION CMNSellSpouse$1,001 - $15,000+43.0%Dec 6, 2022Jan 6, 202331dFilingOCR
DRo KhannaINCYINCYTE CORPORATION CMNUnknownReviewSelf——Sep 28, 2021Oct 14, 202116dFilingOCR
DGilbert Ray Cisneros, Jr.INCYIncyte Corporation (INCY)SellSelf$1,001 - $15,000+67.1%Dec 22, 2020Jan 11, 202120dFiling
DGilbert Ray Cisneros, Jr.INCYIncyte Corporation (INCY)BuySelf$1,001 - $15,000-84.3%Sep 16, 2020Oct 14, 202028dFiling
DRo KhannaINCYINCYTE CORPORATION CMNBuyReviewUnknown$1,001 - $15,000-101.3%Feb 11, 2020Mar 9, 202027dFilingOCR

Insider activity Filed

Insiders
28
Services-Commercial Physical & Biological Research
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
6
$5.8M sold
Net · 90d
-$5.8M
-$57.4M net over 12 months · last Nov 3, 2026
Insider transactions as filed on SEC Form 4
DateInsiderKindSecuritySharesPriceValuePost-holdingsD/I10b5-1Source
Nov 3, 2026filed Nov 5, 2026Thomas TrayPrincipal Accounting OfficerSaleCommon Stock−610$118.96$72,56621,126D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DExerciseEmployee Stock Option (right to buy)deriv.−925$0.00—19,431D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DExerciseEmployee Stock Option (right to buy)deriv.−455$0.00—4,096D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DExerciseEmployee Stock Option (right to buy)deriv.−423$0.00—3,802D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DExerciseEmployee Stock Option (right to buy)deriv.−839$0.00—17,627D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DSaleCommon Stock−2,642$112.71$297,780183,200D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DExerciseCommon Stock925$64.25$59,431185,842D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DExerciseCommon Stock455$61.18$27,837184,917D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DExerciseCommon Stock423$61.76$26,124184,462D10b5-14
Oct 15, 2026filed Oct 19, 2026Pablo J CagnoniPresident, Global Head of R&DExerciseCommon Stock839$71.93$60,349184,039D10b5-14

Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).

Unusual activity Estimated